nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamsulosin—ORM1—Abiraterone—prostate cancer	0.153	0.338	CbGbCtD
Tamsulosin—CYP3A4—prostate cancer	0.148	1	CbGaD
Tamsulosin—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0463	0.102	CbGbCtD
Tamsulosin—CYP2D6—Bicalutamide—prostate cancer	0.0383	0.0845	CbGbCtD
Tamsulosin—CYP2D6—Abiraterone—prostate cancer	0.0317	0.07	CbGbCtD
Tamsulosin—ADRA1B—vas deferens—prostate cancer	0.0277	0.384	CbGeAlD
Tamsulosin—CYP3A4—Bicalutamide—prostate cancer	0.0243	0.0537	CbGbCtD
Tamsulosin—CYP3A4—Estramustine—prostate cancer	0.0226	0.05	CbGbCtD
Tamsulosin—CYP3A4—Flutamide—prostate cancer	0.0202	0.0445	CbGbCtD
Tamsulosin—CYP3A4—Abiraterone—prostate cancer	0.0202	0.0445	CbGbCtD
Tamsulosin—HTR7—vas deferens—prostate cancer	0.0161	0.223	CbGeAlD
Tamsulosin—CYP3A4—Cabazitaxel—prostate cancer	0.0149	0.0329	CbGbCtD
Tamsulosin—CYP3A4—Estrone—prostate cancer	0.0146	0.0322	CbGbCtD
Tamsulosin—CYP3A4—Ethinyl Estradiol—prostate cancer	0.013	0.0287	CbGbCtD
Tamsulosin—CYP3A4—Conjugated Estrogens—prostate cancer	0.00954	0.0211	CbGbCtD
Tamsulosin—CYP3A4—Mitoxantrone—prostate cancer	0.00867	0.0191	CbGbCtD
Tamsulosin—CYP3A4—Estradiol—prostate cancer	0.00837	0.0185	CbGbCtD
Tamsulosin—CYP3A4—Prednisone—prostate cancer	0.0072	0.0159	CbGbCtD
Tamsulosin—CYP2D6—Doxorubicin—prostate cancer	0.00586	0.013	CbGbCtD
Tamsulosin—CYP3A4—Etoposide—prostate cancer	0.00547	0.0121	CbGbCtD
Tamsulosin—CYP3A4—Docetaxel—prostate cancer	0.005	0.011	CbGbCtD
Tamsulosin—CYP3A4—Doxorubicin—prostate cancer	0.00373	0.00823	CbGbCtD
Tamsulosin—ADRA1D—prostate gland—prostate cancer	0.00242	0.0335	CbGeAlD
Tamsulosin—CYP3A4—urine—prostate cancer	0.00232	0.0321	CbGeAlD
Tamsulosin—CYP2D6—urine—prostate cancer	0.00228	0.0316	CbGeAlD
Tamsulosin—ORM1—prostate gland—prostate cancer	0.00199	0.0276	CbGeAlD
Tamsulosin—ADRA1D—epithelium—prostate cancer	0.00178	0.0246	CbGeAlD
Tamsulosin—Bumetanide—SLC12A2—prostate cancer	0.00171	0.264	CrCbGaD
Tamsulosin—ADRA1B—renal system—prostate cancer	0.00168	0.0234	CbGeAlD
Tamsulosin—ADRA1D—urethra—prostate cancer	0.00162	0.0224	CbGeAlD
Tamsulosin—ADRA1A—prostate gland—prostate cancer	0.00139	0.0192	CbGeAlD
Tamsulosin—Carvedilol—GJA1—prostate cancer	0.00135	0.209	CrCbGaD
Tamsulosin—HTR7—epithelium—prostate cancer	0.00106	0.0147	CbGeAlD
Tamsulosin—ADRA2A—prostate gland—prostate cancer	0.00106	0.0146	CbGeAlD
Tamsulosin—HTR1A—renal system—prostate cancer	0.00103	0.0142	CbGeAlD
Tamsulosin—ORM1—bone marrow—prostate cancer	0.00103	0.0142	CbGeAlD
Tamsulosin—Carvedilol—HIF1A—prostate cancer	0.00102	0.158	CrCbGaD
Tamsulosin—ADRA1A—epithelium—prostate cancer	0.00102	0.0141	CbGeAlD
Tamsulosin—HTR7—renal system—prostate cancer	0.000981	0.0136	CbGeAlD
Tamsulosin—ADRA1A—renal system—prostate cancer	0.000947	0.0131	CbGeAlD
Tamsulosin—ADRA2A—seminal vesicle—prostate cancer	0.000893	0.0124	CbGeAlD
Tamsulosin—ADRA2A—urethra—prostate cancer	0.000707	0.0098	CbGeAlD
Tamsulosin—ORM1—lymph node—prostate cancer	0.000636	0.00881	CbGeAlD
Tamsulosin—HTR7—testis—prostate cancer	0.000634	0.00879	CbGeAlD
Tamsulosin—DRD2—testis—prostate cancer	0.0006	0.00831	CbGeAlD
Tamsulosin—CYP3A4—renal system—prostate cancer	0.000567	0.00785	CbGeAlD
Tamsulosin—CYP2D6—renal system—prostate cancer	0.000558	0.00773	CbGeAlD
Tamsulosin—Silodosin—CYP3A4—prostate cancer	0.000517	0.0799	CrCbGaD
Tamsulosin—Bevantolol—ADRB2—prostate cancer	0.000508	0.0785	CrCbGaD
Tamsulosin—ADRA2A—testis—prostate cancer	0.000465	0.00645	CbGeAlD
Tamsulosin—Carvedilol—VEGFA—prostate cancer	0.000412	0.0637	CrCbGaD
Tamsulosin—CYP2D6—testis—prostate cancer	0.00036	0.00499	CbGeAlD
Tamsulosin—ADRA2A—lymph node—prostate cancer	0.000337	0.00467	CbGeAlD
Tamsulosin—Carvedilol—ADRB2—prostate cancer	0.000232	0.0359	CrCbGaD
Tamsulosin—Carvedilol—CYP2E1—prostate cancer	0.000202	0.0312	CrCbGaD
Tamsulosin—Carvedilol—CYP1A1—prostate cancer	0.000199	0.0308	CrCbGaD
Tamsulosin—Bumetanide—PTGS2—prostate cancer	0.000195	0.0301	CrCbGaD
Tamsulosin—Carvedilol—CYP3A4—prostate cancer	0.000127	0.0196	CrCbGaD
Tamsulosin—Sinusitis—Epirubicin—prostate cancer	9.12e-05	0.000408	CcSEcCtD
Tamsulosin—Feeling abnormal—Etoposide—prostate cancer	9.11e-05	0.000407	CcSEcCtD
Tamsulosin—Diarrhoea—Mitoxantrone—prostate cancer	9.1e-05	0.000407	CcSEcCtD
Tamsulosin—Vomiting—Estradiol—prostate cancer	9.07e-05	0.000406	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Etoposide—prostate cancer	9.04e-05	0.000404	CcSEcCtD
Tamsulosin—Shock—Docetaxel—prostate cancer	9.04e-05	0.000404	CcSEcCtD
Tamsulosin—Nervous system disorder—Docetaxel—prostate cancer	9.01e-05	0.000403	CcSEcCtD
Tamsulosin—Ill-defined disorder—Prednisone—prostate cancer	9.01e-05	0.000403	CcSEcCtD
Tamsulosin—Rash—Estradiol—prostate cancer	9e-05	0.000402	CcSEcCtD
Tamsulosin—Infestation—Doxorubicin—prostate cancer	8.99e-05	0.000402	CcSEcCtD
Tamsulosin—Infestation NOS—Doxorubicin—prostate cancer	8.99e-05	0.000402	CcSEcCtD
Tamsulosin—Dermatitis—Estradiol—prostate cancer	8.99e-05	0.000402	CcSEcCtD
Tamsulosin—Tachycardia—Docetaxel—prostate cancer	8.97e-05	0.000401	CcSEcCtD
Tamsulosin—Headache—Estradiol—prostate cancer	8.94e-05	0.0004	CcSEcCtD
Tamsulosin—Skin disorder—Docetaxel—prostate cancer	8.93e-05	0.000399	CcSEcCtD
Tamsulosin—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	8.92e-05	0.000399	CcSEcCtD
Tamsulosin—Angioedema—Prednisone—prostate cancer	8.88e-05	0.000397	CcSEcCtD
Tamsulosin—Infection—Capecitabine—prostate cancer	8.84e-05	0.000395	CcSEcCtD
Tamsulosin—Urticaria—Etoposide—prostate cancer	8.79e-05	0.000393	CcSEcCtD
Tamsulosin—Malaise—Prednisone—prostate cancer	8.76e-05	0.000392	CcSEcCtD
Tamsulosin—Shock—Capecitabine—prostate cancer	8.76e-05	0.000391	CcSEcCtD
Tamsulosin—Rhinitis—Epirubicin—prostate cancer	8.75e-05	0.000391	CcSEcCtD
Tamsulosin—Abdominal pain—Etoposide—prostate cancer	8.74e-05	0.000391	CcSEcCtD
Tamsulosin—Body temperature increased—Etoposide—prostate cancer	8.74e-05	0.000391	CcSEcCtD
Tamsulosin—Urinary tract infection—Doxorubicin—prostate cancer	8.74e-05	0.000391	CcSEcCtD
Tamsulosin—Nervous system disorder—Capecitabine—prostate cancer	8.73e-05	0.00039	CcSEcCtD
Tamsulosin—Vertigo—Prednisone—prostate cancer	8.73e-05	0.00039	CcSEcCtD
Tamsulosin—Syncope—Prednisone—prostate cancer	8.71e-05	0.000389	CcSEcCtD
Tamsulosin—Tachycardia—Capecitabine—prostate cancer	8.69e-05	0.000388	CcSEcCtD
Tamsulosin—Pharyngitis—Epirubicin—prostate cancer	8.66e-05	0.000387	CcSEcCtD
Tamsulosin—Skin disorder—Capecitabine—prostate cancer	8.64e-05	0.000386	CcSEcCtD
Tamsulosin—Sweating—Doxorubicin—prostate cancer	8.62e-05	0.000385	CcSEcCtD
Tamsulosin—Hyperhidrosis—Capecitabine—prostate cancer	8.6e-05	0.000385	CcSEcCtD
Tamsulosin—Oedema peripheral—Epirubicin—prostate cancer	8.6e-05	0.000384	CcSEcCtD
Tamsulosin—Hypotension—Docetaxel—prostate cancer	8.59e-05	0.000384	CcSEcCtD
Tamsulosin—Connective tissue disorder—Epirubicin—prostate cancer	8.58e-05	0.000383	CcSEcCtD
Tamsulosin—Loss of consciousness—Prednisone—prostate cancer	8.54e-05	0.000382	CcSEcCtD
Tamsulosin—Epistaxis—Doxorubicin—prostate cancer	8.48e-05	0.000379	CcSEcCtD
Tamsulosin—Nausea—Estradiol—prostate cancer	8.48e-05	0.000379	CcSEcCtD
Tamsulosin—Vomiting—Mitoxantrone—prostate cancer	8.45e-05	0.000378	CcSEcCtD
Tamsulosin—Sinusitis—Doxorubicin—prostate cancer	8.44e-05	0.000377	CcSEcCtD
Tamsulosin—Visual impairment—Epirubicin—prostate cancer	8.41e-05	0.000376	CcSEcCtD
Tamsulosin—Hypertension—Prednisone—prostate cancer	8.39e-05	0.000375	CcSEcCtD
Tamsulosin—Rash—Mitoxantrone—prostate cancer	8.38e-05	0.000375	CcSEcCtD
Tamsulosin—Dermatitis—Mitoxantrone—prostate cancer	8.38e-05	0.000374	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Docetaxel—prostate cancer	8.37e-05	0.000374	CcSEcCtD
Tamsulosin—Headache—Mitoxantrone—prostate cancer	8.33e-05	0.000372	CcSEcCtD
Tamsulosin—Hypotension—Capecitabine—prostate cancer	8.32e-05	0.000372	CcSEcCtD
Tamsulosin—Insomnia—Docetaxel—prostate cancer	8.31e-05	0.000372	CcSEcCtD
Tamsulosin—Myalgia—Prednisone—prostate cancer	8.27e-05	0.00037	CcSEcCtD
Tamsulosin—Arthralgia—Prednisone—prostate cancer	8.27e-05	0.00037	CcSEcCtD
Tamsulosin—Paraesthesia—Docetaxel—prostate cancer	8.25e-05	0.000369	CcSEcCtD
Tamsulosin—Erythema multiforme—Epirubicin—prostate cancer	8.25e-05	0.000369	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	8.21e-05	0.000367	CcSEcCtD
Tamsulosin—Dyspnoea—Docetaxel—prostate cancer	8.2e-05	0.000366	CcSEcCtD
Tamsulosin—Somnolence—Docetaxel—prostate cancer	8.17e-05	0.000365	CcSEcCtD
Tamsulosin—Discomfort—Prednisone—prostate cancer	8.17e-05	0.000365	CcSEcCtD
Tamsulosin—Hypersensitivity—Etoposide—prostate cancer	8.15e-05	0.000364	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.11e-05	0.000362	CcSEcCtD
Tamsulosin—Cardiac disorder—Epirubicin—prostate cancer	8.1e-05	0.000362	CcSEcCtD
Tamsulosin—Rhinitis—Doxorubicin—prostate cancer	8.1e-05	0.000362	CcSEcCtD
Tamsulosin—Dyspepsia—Docetaxel—prostate cancer	8.09e-05	0.000362	CcSEcCtD
Tamsulosin—Insomnia—Capecitabine—prostate cancer	8.05e-05	0.00036	CcSEcCtD
Tamsulosin—Pharyngitis—Doxorubicin—prostate cancer	8.01e-05	0.000358	CcSEcCtD
Tamsulosin—Paraesthesia—Capecitabine—prostate cancer	7.99e-05	0.000357	CcSEcCtD
Tamsulosin—Oedema peripheral—Doxorubicin—prostate cancer	7.95e-05	0.000356	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Docetaxel—prostate cancer	7.94e-05	0.000355	CcSEcCtD
Tamsulosin—Asthenia—Etoposide—prostate cancer	7.94e-05	0.000355	CcSEcCtD
Tamsulosin—Connective tissue disorder—Doxorubicin—prostate cancer	7.93e-05	0.000355	CcSEcCtD
Tamsulosin—Dyspnoea—Capecitabine—prostate cancer	7.93e-05	0.000355	CcSEcCtD
Tamsulosin—Fatigue—Docetaxel—prostate cancer	7.93e-05	0.000354	CcSEcCtD
Tamsulosin—Angiopathy—Epirubicin—prostate cancer	7.92e-05	0.000354	CcSEcCtD
Tamsulosin—Nausea—Mitoxantrone—prostate cancer	7.9e-05	0.000353	CcSEcCtD
Tamsulosin—Infection—Prednisone—prostate cancer	7.88e-05	0.000352	CcSEcCtD
Tamsulosin—Mediastinal disorder—Epirubicin—prostate cancer	7.87e-05	0.000352	CcSEcCtD
Tamsulosin—Pain—Docetaxel—prostate cancer	7.86e-05	0.000351	CcSEcCtD
Tamsulosin—Constipation—Docetaxel—prostate cancer	7.86e-05	0.000351	CcSEcCtD
Tamsulosin—Dyspepsia—Capecitabine—prostate cancer	7.83e-05	0.00035	CcSEcCtD
Tamsulosin—Chills—Epirubicin—prostate cancer	7.83e-05	0.00035	CcSEcCtD
Tamsulosin—Pruritus—Etoposide—prostate cancer	7.83e-05	0.00035	CcSEcCtD
Tamsulosin—Shock—Prednisone—prostate cancer	7.8e-05	0.000349	CcSEcCtD
Tamsulosin—Arrhythmia—Epirubicin—prostate cancer	7.8e-05	0.000348	CcSEcCtD
Tamsulosin—Visual impairment—Doxorubicin—prostate cancer	7.78e-05	0.000348	CcSEcCtD
Tamsulosin—Nervous system disorder—Prednisone—prostate cancer	7.77e-05	0.000348	CcSEcCtD
Tamsulosin—Tachycardia—Prednisone—prostate cancer	7.74e-05	0.000346	CcSEcCtD
Tamsulosin—Skin disorder—Prednisone—prostate cancer	7.7e-05	0.000344	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Capecitabine—prostate cancer	7.68e-05	0.000343	CcSEcCtD
Tamsulosin—Fatigue—Capecitabine—prostate cancer	7.67e-05	0.000343	CcSEcCtD
Tamsulosin—Hyperhidrosis—Prednisone—prostate cancer	7.66e-05	0.000343	CcSEcCtD
Tamsulosin—Erythema multiforme—Doxorubicin—prostate cancer	7.63e-05	0.000341	CcSEcCtD
Tamsulosin—Constipation—Capecitabine—prostate cancer	7.61e-05	0.00034	CcSEcCtD
Tamsulosin—Pain—Capecitabine—prostate cancer	7.61e-05	0.00034	CcSEcCtD
Tamsulosin—Malnutrition—Epirubicin—prostate cancer	7.6e-05	0.00034	CcSEcCtD
Tamsulosin—Feeling abnormal—Docetaxel—prostate cancer	7.57e-05	0.000339	CcSEcCtD
Tamsulosin—Diarrhoea—Etoposide—prostate cancer	7.57e-05	0.000338	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Docetaxel—prostate cancer	7.52e-05	0.000336	CcSEcCtD
Tamsulosin—Cardiac disorder—Doxorubicin—prostate cancer	7.49e-05	0.000335	CcSEcCtD
Tamsulosin—Back pain—Epirubicin—prostate cancer	7.35e-05	0.000328	CcSEcCtD
Tamsulosin—Feeling abnormal—Capecitabine—prostate cancer	7.33e-05	0.000328	CcSEcCtD
Tamsulosin—Angiopathy—Doxorubicin—prostate cancer	7.33e-05	0.000327	CcSEcCtD
Tamsulosin—Dizziness—Etoposide—prostate cancer	7.31e-05	0.000327	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Capecitabine—prostate cancer	7.28e-05	0.000325	CcSEcCtD
Tamsulosin—Mediastinal disorder—Doxorubicin—prostate cancer	7.28e-05	0.000325	CcSEcCtD
Tamsulosin—Abdominal pain—Docetaxel—prostate cancer	7.27e-05	0.000325	CcSEcCtD
Tamsulosin—Body temperature increased—Docetaxel—prostate cancer	7.27e-05	0.000325	CcSEcCtD
Tamsulosin—Chills—Doxorubicin—prostate cancer	7.25e-05	0.000324	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Prednisone—prostate cancer	7.22e-05	0.000323	CcSEcCtD
Tamsulosin—Arrhythmia—Doxorubicin—prostate cancer	7.21e-05	0.000322	CcSEcCtD
Tamsulosin—Insomnia—Prednisone—prostate cancer	7.17e-05	0.00032	CcSEcCtD
Tamsulosin—Vision blurred—Epirubicin—prostate cancer	7.16e-05	0.00032	CcSEcCtD
Tamsulosin—Paraesthesia—Prednisone—prostate cancer	7.12e-05	0.000318	CcSEcCtD
Tamsulosin—Urticaria—Capecitabine—prostate cancer	7.07e-05	0.000316	CcSEcCtD
Tamsulosin—Ill-defined disorder—Epirubicin—prostate cancer	7.05e-05	0.000315	CcSEcCtD
Tamsulosin—Abdominal pain—Capecitabine—prostate cancer	7.04e-05	0.000314	CcSEcCtD
Tamsulosin—Body temperature increased—Capecitabine—prostate cancer	7.04e-05	0.000314	CcSEcCtD
Tamsulosin—Vomiting—Etoposide—prostate cancer	7.03e-05	0.000314	CcSEcCtD
Tamsulosin—Malnutrition—Doxorubicin—prostate cancer	7.03e-05	0.000314	CcSEcCtD
Tamsulosin—Dyspepsia—Prednisone—prostate cancer	6.98e-05	0.000312	CcSEcCtD
Tamsulosin—Rash—Etoposide—prostate cancer	6.97e-05	0.000312	CcSEcCtD
Tamsulosin—Dermatitis—Etoposide—prostate cancer	6.97e-05	0.000311	CcSEcCtD
Tamsulosin—Headache—Etoposide—prostate cancer	6.93e-05	0.00031	CcSEcCtD
Tamsulosin—Malaise—Epirubicin—prostate cancer	6.85e-05	0.000306	CcSEcCtD
Tamsulosin—Fatigue—Prednisone—prostate cancer	6.83e-05	0.000306	CcSEcCtD
Tamsulosin—Vertigo—Epirubicin—prostate cancer	6.83e-05	0.000305	CcSEcCtD
Tamsulosin—Syncope—Epirubicin—prostate cancer	6.81e-05	0.000305	CcSEcCtD
Tamsulosin—Back pain—Doxorubicin—prostate cancer	6.8e-05	0.000304	CcSEcCtD
Tamsulosin—Constipation—Prednisone—prostate cancer	6.78e-05	0.000303	CcSEcCtD
Tamsulosin—Hypersensitivity—Docetaxel—prostate cancer	6.77e-05	0.000303	CcSEcCtD
Tamsulosin—Palpitations—Epirubicin—prostate cancer	6.71e-05	0.0003	CcSEcCtD
Tamsulosin—Loss of consciousness—Epirubicin—prostate cancer	6.68e-05	0.000298	CcSEcCtD
Tamsulosin—Cough—Epirubicin—prostate cancer	6.63e-05	0.000296	CcSEcCtD
Tamsulosin—Vision blurred—Doxorubicin—prostate cancer	6.62e-05	0.000296	CcSEcCtD
Tamsulosin—Asthenia—Docetaxel—prostate cancer	6.6e-05	0.000295	CcSEcCtD
Tamsulosin—Nausea—Etoposide—prostate cancer	6.57e-05	0.000294	CcSEcCtD
Tamsulosin—Hypertension—Epirubicin—prostate cancer	6.56e-05	0.000293	CcSEcCtD
Tamsulosin—Hypersensitivity—Capecitabine—prostate cancer	6.56e-05	0.000293	CcSEcCtD
Tamsulosin—Feeling abnormal—Prednisone—prostate cancer	6.53e-05	0.000292	CcSEcCtD
Tamsulosin—Ill-defined disorder—Doxorubicin—prostate cancer	6.52e-05	0.000292	CcSEcCtD
Tamsulosin—Pruritus—Docetaxel—prostate cancer	6.5e-05	0.000291	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Prednisone—prostate cancer	6.48e-05	0.00029	CcSEcCtD
Tamsulosin—Arthralgia—Epirubicin—prostate cancer	6.47e-05	0.000289	CcSEcCtD
Tamsulosin—Myalgia—Epirubicin—prostate cancer	6.47e-05	0.000289	CcSEcCtD
Tamsulosin—Chest pain—Epirubicin—prostate cancer	6.47e-05	0.000289	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	6.42e-05	0.000287	CcSEcCtD
Tamsulosin—Discomfort—Epirubicin—prostate cancer	6.39e-05	0.000286	CcSEcCtD
Tamsulosin—Asthenia—Capecitabine—prostate cancer	6.39e-05	0.000285	CcSEcCtD
Tamsulosin—Malaise—Doxorubicin—prostate cancer	6.34e-05	0.000283	CcSEcCtD
Tamsulosin—Vertigo—Doxorubicin—prostate cancer	6.32e-05	0.000282	CcSEcCtD
Tamsulosin—Syncope—Doxorubicin—prostate cancer	6.3e-05	0.000282	CcSEcCtD
Tamsulosin—Urticaria—Prednisone—prostate cancer	6.3e-05	0.000282	CcSEcCtD
Tamsulosin—Pruritus—Capecitabine—prostate cancer	6.3e-05	0.000281	CcSEcCtD
Tamsulosin—Diarrhoea—Docetaxel—prostate cancer	6.29e-05	0.000281	CcSEcCtD
Tamsulosin—Abdominal pain—Prednisone—prostate cancer	6.27e-05	0.00028	CcSEcCtD
Tamsulosin—Body temperature increased—Prednisone—prostate cancer	6.27e-05	0.00028	CcSEcCtD
Tamsulosin—Palpitations—Doxorubicin—prostate cancer	6.21e-05	0.000278	CcSEcCtD
Tamsulosin—Loss of consciousness—Doxorubicin—prostate cancer	6.18e-05	0.000276	CcSEcCtD
Tamsulosin—Infection—Epirubicin—prostate cancer	6.16e-05	0.000275	CcSEcCtD
Tamsulosin—Cough—Doxorubicin—prostate cancer	6.13e-05	0.000274	CcSEcCtD
Tamsulosin—Shock—Epirubicin—prostate cancer	6.1e-05	0.000273	CcSEcCtD
Tamsulosin—Diarrhoea—Capecitabine—prostate cancer	6.09e-05	0.000272	CcSEcCtD
Tamsulosin—Nervous system disorder—Epirubicin—prostate cancer	6.08e-05	0.000272	CcSEcCtD
Tamsulosin—Dizziness—Docetaxel—prostate cancer	6.08e-05	0.000272	CcSEcCtD
Tamsulosin—Hypertension—Doxorubicin—prostate cancer	6.07e-05	0.000271	CcSEcCtD
Tamsulosin—Tachycardia—Epirubicin—prostate cancer	6.05e-05	0.00027	CcSEcCtD
Tamsulosin—Skin disorder—Epirubicin—prostate cancer	6.02e-05	0.000269	CcSEcCtD
Tamsulosin—Hyperhidrosis—Epirubicin—prostate cancer	5.99e-05	0.000268	CcSEcCtD
Tamsulosin—Arthralgia—Doxorubicin—prostate cancer	5.98e-05	0.000267	CcSEcCtD
Tamsulosin—Myalgia—Doxorubicin—prostate cancer	5.98e-05	0.000267	CcSEcCtD
Tamsulosin—Chest pain—Doxorubicin—prostate cancer	5.98e-05	0.000267	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	5.94e-05	0.000266	CcSEcCtD
Tamsulosin—Discomfort—Doxorubicin—prostate cancer	5.91e-05	0.000264	CcSEcCtD
Tamsulosin—Dizziness—Capecitabine—prostate cancer	5.89e-05	0.000263	CcSEcCtD
Tamsulosin—Vomiting—Docetaxel—prostate cancer	5.84e-05	0.000261	CcSEcCtD
Tamsulosin—Hypersensitivity—Prednisone—prostate cancer	5.84e-05	0.000261	CcSEcCtD
Tamsulosin—Rash—Docetaxel—prostate cancer	5.8e-05	0.000259	CcSEcCtD
Tamsulosin—Hypotension—Epirubicin—prostate cancer	5.79e-05	0.000259	CcSEcCtD
Tamsulosin—Dermatitis—Docetaxel—prostate cancer	5.79e-05	0.000259	CcSEcCtD
Tamsulosin—Headache—Docetaxel—prostate cancer	5.76e-05	0.000257	CcSEcCtD
Tamsulosin—Infection—Doxorubicin—prostate cancer	5.7e-05	0.000255	CcSEcCtD
Tamsulosin—Asthenia—Prednisone—prostate cancer	5.69e-05	0.000254	CcSEcCtD
Tamsulosin—Vomiting—Capecitabine—prostate cancer	5.66e-05	0.000253	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.65e-05	0.000252	CcSEcCtD
Tamsulosin—Shock—Doxorubicin—prostate cancer	5.64e-05	0.000252	CcSEcCtD
Tamsulosin—Nervous system disorder—Doxorubicin—prostate cancer	5.63e-05	0.000251	CcSEcCtD
Tamsulosin—Rash—Capecitabine—prostate cancer	5.61e-05	0.000251	CcSEcCtD
Tamsulosin—Pruritus—Prednisone—prostate cancer	5.61e-05	0.000251	CcSEcCtD
Tamsulosin—Insomnia—Epirubicin—prostate cancer	5.61e-05	0.000251	CcSEcCtD
Tamsulosin—Dermatitis—Capecitabine—prostate cancer	5.61e-05	0.000251	CcSEcCtD
Tamsulosin—Tachycardia—Doxorubicin—prostate cancer	5.6e-05	0.00025	CcSEcCtD
Tamsulosin—Headache—Capecitabine—prostate cancer	5.58e-05	0.000249	CcSEcCtD
Tamsulosin—Skin disorder—Doxorubicin—prostate cancer	5.57e-05	0.000249	CcSEcCtD
Tamsulosin—Paraesthesia—Epirubicin—prostate cancer	5.57e-05	0.000249	CcSEcCtD
Tamsulosin—Hyperhidrosis—Doxorubicin—prostate cancer	5.55e-05	0.000248	CcSEcCtD
Tamsulosin—Dyspnoea—Epirubicin—prostate cancer	5.53e-05	0.000247	CcSEcCtD
Tamsulosin—Somnolence—Epirubicin—prostate cancer	5.51e-05	0.000246	CcSEcCtD
Tamsulosin—Nausea—Docetaxel—prostate cancer	5.46e-05	0.000244	CcSEcCtD
Tamsulosin—Dyspepsia—Epirubicin—prostate cancer	5.46e-05	0.000244	CcSEcCtD
Tamsulosin—Diarrhoea—Prednisone—prostate cancer	5.42e-05	0.000242	CcSEcCtD
Tamsulosin—Hypotension—Doxorubicin—prostate cancer	5.36e-05	0.00024	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Epirubicin—prostate cancer	5.35e-05	0.000239	CcSEcCtD
Tamsulosin—Fatigue—Epirubicin—prostate cancer	5.35e-05	0.000239	CcSEcCtD
Tamsulosin—Constipation—Epirubicin—prostate cancer	5.3e-05	0.000237	CcSEcCtD
Tamsulosin—Pain—Epirubicin—prostate cancer	5.3e-05	0.000237	CcSEcCtD
Tamsulosin—Nausea—Capecitabine—prostate cancer	5.29e-05	0.000236	CcSEcCtD
Tamsulosin—Dizziness—Prednisone—prostate cancer	5.24e-05	0.000234	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.23e-05	0.000234	CcSEcCtD
Tamsulosin—Insomnia—Doxorubicin—prostate cancer	5.19e-05	0.000232	CcSEcCtD
Tamsulosin—Paraesthesia—Doxorubicin—prostate cancer	5.15e-05	0.00023	CcSEcCtD
Tamsulosin—Dyspnoea—Doxorubicin—prostate cancer	5.11e-05	0.000229	CcSEcCtD
Tamsulosin—Feeling abnormal—Epirubicin—prostate cancer	5.11e-05	0.000228	CcSEcCtD
Tamsulosin—Somnolence—Doxorubicin—prostate cancer	5.1e-05	0.000228	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Epirubicin—prostate cancer	5.07e-05	0.000227	CcSEcCtD
Tamsulosin—Dyspepsia—Doxorubicin—prostate cancer	5.05e-05	0.000226	CcSEcCtD
Tamsulosin—Vomiting—Prednisone—prostate cancer	5.04e-05	0.000225	CcSEcCtD
Tamsulosin—Rash—Prednisone—prostate cancer	5e-05	0.000223	CcSEcCtD
Tamsulosin—Dermatitis—Prednisone—prostate cancer	4.99e-05	0.000223	CcSEcCtD
Tamsulosin—Headache—Prednisone—prostate cancer	4.97e-05	0.000222	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.95e-05	0.000221	CcSEcCtD
Tamsulosin—Fatigue—Doxorubicin—prostate cancer	4.95e-05	0.000221	CcSEcCtD
Tamsulosin—Urticaria—Epirubicin—prostate cancer	4.93e-05	0.00022	CcSEcCtD
Tamsulosin—Pain—Doxorubicin—prostate cancer	4.91e-05	0.000219	CcSEcCtD
Tamsulosin—Constipation—Doxorubicin—prostate cancer	4.91e-05	0.000219	CcSEcCtD
Tamsulosin—Body temperature increased—Epirubicin—prostate cancer	4.9e-05	0.000219	CcSEcCtD
Tamsulosin—Abdominal pain—Epirubicin—prostate cancer	4.9e-05	0.000219	CcSEcCtD
Tamsulosin—Feeling abnormal—Doxorubicin—prostate cancer	4.73e-05	0.000211	CcSEcCtD
Tamsulosin—Nausea—Prednisone—prostate cancer	4.71e-05	0.00021	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Doxorubicin—prostate cancer	4.69e-05	0.00021	CcSEcCtD
Tamsulosin—Hypersensitivity—Epirubicin—prostate cancer	4.57e-05	0.000204	CcSEcCtD
Tamsulosin—Urticaria—Doxorubicin—prostate cancer	4.56e-05	0.000204	CcSEcCtD
Tamsulosin—Abdominal pain—Doxorubicin—prostate cancer	4.54e-05	0.000203	CcSEcCtD
Tamsulosin—Body temperature increased—Doxorubicin—prostate cancer	4.54e-05	0.000203	CcSEcCtD
Tamsulosin—Asthenia—Epirubicin—prostate cancer	4.45e-05	0.000199	CcSEcCtD
Tamsulosin—Pruritus—Epirubicin—prostate cancer	4.39e-05	0.000196	CcSEcCtD
Tamsulosin—Diarrhoea—Epirubicin—prostate cancer	4.24e-05	0.00019	CcSEcCtD
Tamsulosin—Hypersensitivity—Doxorubicin—prostate cancer	4.23e-05	0.000189	CcSEcCtD
Tamsulosin—Asthenia—Doxorubicin—prostate cancer	4.12e-05	0.000184	CcSEcCtD
Tamsulosin—Dizziness—Epirubicin—prostate cancer	4.1e-05	0.000183	CcSEcCtD
Tamsulosin—Pruritus—Doxorubicin—prostate cancer	4.06e-05	0.000181	CcSEcCtD
Tamsulosin—Vomiting—Epirubicin—prostate cancer	3.94e-05	0.000176	CcSEcCtD
Tamsulosin—Diarrhoea—Doxorubicin—prostate cancer	3.93e-05	0.000175	CcSEcCtD
Tamsulosin—Rash—Epirubicin—prostate cancer	3.91e-05	0.000175	CcSEcCtD
Tamsulosin—Dermatitis—Epirubicin—prostate cancer	3.91e-05	0.000175	CcSEcCtD
Tamsulosin—Headache—Epirubicin—prostate cancer	3.88e-05	0.000174	CcSEcCtD
Tamsulosin—Dizziness—Doxorubicin—prostate cancer	3.79e-05	0.00017	CcSEcCtD
Tamsulosin—Nausea—Epirubicin—prostate cancer	3.68e-05	0.000165	CcSEcCtD
Tamsulosin—Vomiting—Doxorubicin—prostate cancer	3.65e-05	0.000163	CcSEcCtD
Tamsulosin—Rash—Doxorubicin—prostate cancer	3.62e-05	0.000162	CcSEcCtD
Tamsulosin—Dermatitis—Doxorubicin—prostate cancer	3.61e-05	0.000162	CcSEcCtD
Tamsulosin—Headache—Doxorubicin—prostate cancer	3.59e-05	0.000161	CcSEcCtD
Tamsulosin—Nausea—Doxorubicin—prostate cancer	3.41e-05	0.000152	CcSEcCtD
Tamsulosin—DRD3—Signaling Pathways—CDKN1A—prostate cancer	3.76e-06	3.89e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—CDKN1A—prostate cancer	3.76e-06	3.89e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—PTEN—prostate cancer	3.75e-06	3.88e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—PTEN—prostate cancer	3.75e-06	3.88e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—KRAS—prostate cancer	3.73e-06	3.86e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—GSK3B—prostate cancer	3.73e-06	3.85e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—PIK3CA—prostate cancer	3.72e-06	3.85e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MDM2—prostate cancer	3.71e-06	3.83e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MAP2K1—prostate cancer	3.7e-06	3.82e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—INS—prostate cancer	3.68e-06	3.8e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CD—prostate cancer	3.67e-06	3.8e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—MYC—prostate cancer	3.67e-06	3.79e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling by GPCR—AKT1—prostate cancer	3.66e-06	3.79e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling by GPCR—AKT1—prostate cancer	3.66e-06	3.79e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—TGFB1—prostate cancer	3.66e-06	3.78e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—ERBB2—prostate cancer	3.65e-06	3.78e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—FGF2—prostate cancer	3.65e-06	3.77e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—PIK3CA—prostate cancer	3.64e-06	3.76e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CXCL8—prostate cancer	3.64e-06	3.76e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—SERPINE1—prostate cancer	3.63e-06	3.76e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PIK3CB—prostate cancer	3.61e-06	3.73e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—MTHFR—prostate cancer	3.6e-06	3.72e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—NOS3—prostate cancer	3.6e-06	3.72e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CREBBP—prostate cancer	3.6e-06	3.72e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.6e-06	3.72e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—KRAS—prostate cancer	3.6e-06	3.72e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—EGFR—prostate cancer	3.59e-06	3.71e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—EP300—prostate cancer	3.58e-06	3.7e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—EP300—prostate cancer	3.58e-06	3.7e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PIK3CB—prostate cancer	3.56e-06	3.68e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IGF1—prostate cancer	3.56e-06	3.68e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CDKN1B—prostate cancer	3.55e-06	3.67e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—EGFR—prostate cancer	3.54e-06	3.66e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PPARA—prostate cancer	3.53e-06	3.65e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PTGS2—prostate cancer	3.53e-06	3.64e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—FGF2—prostate cancer	3.52e-06	3.64e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.52e-06	3.63e-05	CbGpPWpGaD
Tamsulosin—HTR1A—GPCR downstream signaling—AKT1—prostate cancer	3.51e-06	3.63e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—JAK2—prostate cancer	3.5e-06	3.62e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CASP3—prostate cancer	3.48e-06	3.6e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—SRC—prostate cancer	3.48e-06	3.6e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—SRC—prostate cancer	3.48e-06	3.6e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—IL2—prostate cancer	3.48e-06	3.59e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—NQO1—prostate cancer	3.48e-06	3.59e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—NOS3—prostate cancer	3.47e-06	3.59e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CXCL8—prostate cancer	3.47e-06	3.58e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—IL6—prostate cancer	3.46e-06	3.58e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MAP2K1—prostate cancer	3.44e-06	3.55e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	3.43e-06	3.55e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—TH—prostate cancer	3.43e-06	3.54e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MDM2—prostate cancer	3.42e-06	3.53e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CD—prostate cancer	3.41e-06	3.53e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—VEGFA—prostate cancer	3.39e-06	3.5e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—VEGFA—prostate cancer	3.39e-06	3.5e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—KRAS—prostate cancer	3.39e-06	3.5e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CCND1—prostate cancer	3.39e-06	3.5e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CDKN1B—prostate cancer	3.38e-06	3.5e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—PIK3CA—prostate cancer	3.38e-06	3.5e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—SERPINE1—prostate cancer	3.38e-06	3.49e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—JAK2—prostate cancer	3.37e-06	3.49e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—ERBB2—prostate cancer	3.37e-06	3.48e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—STAT3—prostate cancer	3.36e-06	3.47e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—STAT3—prostate cancer	3.36e-06	3.47e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CTNNB1—prostate cancer	3.36e-06	3.47e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—GPCR downstream signaling—AKT1—prostate cancer	3.35e-06	3.46e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—KRAS—prostate cancer	3.34e-06	3.45e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.33e-06	3.45e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PIK3CB—prostate cancer	3.32e-06	3.44e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—CAV1—prostate cancer	3.32e-06	3.43e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CASP3—prostate cancer	3.32e-06	3.43e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—IL2—prostate cancer	3.31e-06	3.42e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—PIK3CA—prostate cancer	3.31e-06	3.42e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—IL6—prostate cancer	3.29e-06	3.41e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MDM2—prostate cancer	3.29e-06	3.4e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MMP9—prostate cancer	3.29e-06	3.4e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CDKN1A—prostate cancer	3.28e-06	3.39e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—PTEN—prostate cancer	3.27e-06	3.38e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—FGF2—prostate cancer	3.27e-06	3.38e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—ERBB2—prostate cancer	3.25e-06	3.35e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GGT1—prostate cancer	3.23e-06	3.34e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CCND1—prostate cancer	3.23e-06	3.34e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—NOS3—prostate cancer	3.22e-06	3.33e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CB—prostate cancer	3.2e-06	3.31e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CTNNB1—prostate cancer	3.2e-06	3.3e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CXCL8—prostate cancer	3.19e-06	3.3e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—AKT1—prostate cancer	3.19e-06	3.3e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—NCOA1—prostate cancer	3.18e-06	3.29e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MMP9—prostate cancer	3.13e-06	3.24e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.13e-06	3.24e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—JAK2—prostate cancer	3.13e-06	3.24e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CDKN1A—prostate cancer	3.12e-06	3.23e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—EP300—prostate cancer	3.12e-06	3.22e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MYC—prostate cancer	3.12e-06	3.22e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CDKN1B—prostate cancer	3.12e-06	3.22e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MYC—prostate cancer	3.12e-06	3.22e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PTEN—prostate cancer	3.12e-06	3.22e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—PIK3CA—prostate cancer	3.11e-06	3.22e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—TGFB1—prostate cancer	3.11e-06	3.22e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—TGFB1—prostate cancer	3.11e-06	3.22e-05	CbGpPWpGaD
Tamsulosin—DRD2—GPCR downstream signaling—AKT1—prostate cancer	3.09e-06	3.19e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CXCL8—prostate cancer	3.08e-06	3.18e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PTEN—prostate cancer	3.08e-06	3.18e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—PIK3CA—prostate cancer	3.07e-06	3.17e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MDM2—prostate cancer	3.06e-06	3.16e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CASP3—prostate cancer	3.06e-06	3.16e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—IL2—prostate cancer	3.05e-06	3.16e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—EGFR—prostate cancer	3.05e-06	3.15e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—EGFR—prostate cancer	3.05e-06	3.15e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—AKT1—prostate cancer	3.04e-06	3.14e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—IL6—prostate cancer	3.04e-06	3.14e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—SRC—prostate cancer	3.03e-06	3.14e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CG—prostate cancer	3.03e-06	3.13e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—RXRA—prostate cancer	3.02e-06	3.13e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	3.02e-06	3.12e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—TP53—prostate cancer	3.01e-06	3.11e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	3.01e-06	3.11e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CCND1—prostate cancer	2.98e-06	3.08e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	2.98e-06	3.08e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	2.97e-06	3.07e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—EP300—prostate cancer	2.97e-06	3.07e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—VEGFA—prostate cancer	2.96e-06	3.05e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CTNNB1—prostate cancer	2.95e-06	3.05e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CASP3—prostate cancer	2.95e-06	3.04e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—IL2—prostate cancer	2.94e-06	3.04e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—EP300—prostate cancer	2.93e-06	3.03e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—IL6—prostate cancer	2.93e-06	3.02e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—STAT3—prostate cancer	2.93e-06	3.02e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—COMT—prostate cancer	2.91e-06	3.01e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GSTP1—prostate cancer	2.9e-06	3e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—SRC—prostate cancer	2.89e-06	2.99e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MMP9—prostate cancer	2.89e-06	2.99e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—KRAS—prostate cancer	2.88e-06	2.98e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—KRAS—prostate cancer	2.88e-06	2.98e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CDKN1A—prostate cancer	2.88e-06	2.98e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PTEN—prostate cancer	2.87e-06	2.97e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CCND1—prostate cancer	2.87e-06	2.96e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—INS—prostate cancer	2.86e-06	2.96e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	2.86e-06	2.96e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—ITPR1—prostate cancer	2.85e-06	2.95e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	2.84e-06	2.93e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—VEGFA—prostate cancer	2.81e-06	2.91e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—CREBBP—prostate cancer	2.81e-06	2.9e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—AKT1—prostate cancer	2.8e-06	2.9e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	2.79e-06	2.89e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—STAT3—prostate cancer	2.79e-06	2.88e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MMP9—prostate cancer	2.78e-06	2.88e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	2.77e-06	2.87e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PTEN—prostate cancer	2.77e-06	2.86e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	2.76e-06	2.86e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—IL6—prostate cancer	2.76e-06	2.85e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—EP300—prostate cancer	2.74e-06	2.83e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CASP3—prostate cancer	2.74e-06	2.83e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IL2—prostate cancer	2.73e-06	2.82e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—IL6—prostate cancer	2.72e-06	2.81e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MYC—prostate cancer	2.72e-06	2.81e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—TGFB1—prostate cancer	2.71e-06	2.8e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	2.7e-06	2.79e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—TYMS—prostate cancer	2.7e-06	2.79e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GSTM1—prostate cancer	2.66e-06	2.75e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CCND1—prostate cancer	2.66e-06	2.75e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—SRC—prostate cancer	2.66e-06	2.75e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.66e-06	2.75e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—EGFR—prostate cancer	2.66e-06	2.75e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—PIK3CA—prostate cancer	2.65e-06	2.74e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—PIK3CA—prostate cancer	2.65e-06	2.74e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—EP300—prostate cancer	2.64e-06	2.73e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	2.64e-06	2.73e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—LPL—prostate cancer	2.62e-06	2.7e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—VEGFA—prostate cancer	2.59e-06	2.68e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MYC—prostate cancer	2.59e-06	2.68e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MMP9—prostate cancer	2.59e-06	2.67e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	2.58e-06	2.67e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	2.58e-06	2.66e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PTEN—prostate cancer	2.57e-06	2.66e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—STAT3—prostate cancer	2.57e-06	2.66e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—SRC—prostate cancer	2.57e-06	2.65e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—TP53—prostate cancer	2.56e-06	2.65e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—TP53—prostate cancer	2.56e-06	2.65e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—AKT1—prostate cancer	2.54e-06	2.63e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—EGFR—prostate cancer	2.53e-06	2.62e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.53e-06	2.61e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—NOS3—prostate cancer	2.51e-06	2.6e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—KRAS—prostate cancer	2.51e-06	2.6e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	2.51e-06	2.59e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—ERCC2—prostate cancer	2.51e-06	2.59e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	2.5e-06	2.58e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—STAT3—prostate cancer	2.48e-06	2.56e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—EP300—prostate cancer	2.45e-06	2.53e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—KRAS—prostate cancer	2.39e-06	2.47e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MYC—prostate cancer	2.39e-06	2.47e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—SRC—prostate cancer	2.38e-06	2.46e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—TGFB1—prostate cancer	2.38e-06	2.46e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—MTHFR—prostate cancer	2.36e-06	2.43e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—IL6—prostate cancer	2.35e-06	2.42e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—IL6—prostate cancer	2.35e-06	2.42e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—EGFR—prostate cancer	2.33e-06	2.41e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	2.32e-06	2.4e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.32e-06	2.4e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PPARA—prostate cancer	2.31e-06	2.39e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	2.31e-06	2.39e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MYC—prostate cancer	2.3e-06	2.38e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—STAT3—prostate cancer	2.3e-06	2.38e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PTGS2—prostate cancer	2.3e-06	2.37e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	2.29e-06	2.37e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—EGFR—prostate cancer	2.25e-06	2.33e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—TP53—prostate cancer	2.23e-06	2.31e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—KRAS—prostate cancer	2.21e-06	2.28e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	2.2e-06	2.27e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CAV1—prostate cancer	2.17e-06	2.25e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PIK3CA—prostate cancer	2.17e-06	2.24e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—AKT1—prostate cancer	2.16e-06	2.24e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—AKT1—prostate cancer	2.16e-06	2.24e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MYC—prostate cancer	2.14e-06	2.21e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	2.13e-06	2.2e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—TP53—prostate cancer	2.13e-06	2.2e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—KRAS—prostate cancer	2.13e-06	2.2e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—EGFR—prostate cancer	2.09e-06	2.16e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—IL6—prostate cancer	2.04e-06	2.11e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PIK3CA—prostate cancer	2.03e-06	2.09e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PTEN—prostate cancer	2e-06	2.07e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.98e-06	2.05e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—KRAS—prostate cancer	1.97e-06	2.04e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—TP53—prostate cancer	1.96e-06	2.03e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	1.95e-06	2.02e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—IL6—prostate cancer	1.95e-06	2.01e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—EP300—prostate cancer	1.91e-06	1.98e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—TP53—prostate cancer	1.89e-06	1.95e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—AKT1—prostate cancer	1.89e-06	1.95e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—INS—prostate cancer	1.87e-06	1.94e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CREBBP—prostate cancer	1.83e-06	1.9e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	1.81e-06	1.87e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—AKT1—prostate cancer	1.8e-06	1.86e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—IL6—prostate cancer	1.79e-06	1.85e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—AKT1—prostate cancer	1.77e-06	1.83e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—TP53—prostate cancer	1.75e-06	1.81e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.74e-06	1.8e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—IL6—prostate cancer	1.73e-06	1.79e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—AKT1—prostate cancer	1.66e-06	1.71e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—NOS3—prostate cancer	1.64e-06	1.7e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IL6—prostate cancer	1.61e-06	1.66e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—AKT1—prostate cancer	1.59e-06	1.65e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.52e-06	1.57e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PTGS2—prostate cancer	1.5e-06	1.55e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—AKT1—prostate cancer	1.48e-06	1.53e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.41e-06	1.46e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PTEN—prostate cancer	1.31e-06	1.35e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—EP300—prostate cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—AKT1—prostate cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.24e-07	9.55e-06	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—AKT1—prostate cancer	7.55e-07	7.8e-06	CbGpPWpGaD
